• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • WCW HOME
  • Submit a Wire!
  • Advertising
  • Media Partners
  • About
  • Contact Us

WorkCompWire

Your Trusted Source for Workers Compensation News

Enlyte
  • Workers Compensation News
    • Workers Compensation Industry News
    • Association, Rating & Research News
    • Claims, Legal, & Compliance News
    • Legislative & Regulatory News
    • Risk Management News
    • Work Force & Human Resource News
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • People On The Move

Coventry Releases Part Three of 2019 Workers’ Comp Drug Trends Series Report

August 7, 2020 - WorkCompWire

Downers Grove, IL – Coventry recently released part three of the 2019 edition of its annual Drug Trends Series Report, which evaluates opioid trends.

Coventry noted that opioids continue to represent a decreasing proportion of overall scripts and costs, with favorable trends seen in important markers such as morphine equivalent dose (MED), duration of use, and access to guideline-supported measures including medication-assisted treatment (MAT) and overdose rescue medication (naloxone).

Key highlights from the series include:

  • The number of injured workers using opioids has continued to decline for 6 consecutive years
  • Opioid script utilization has fallen at least 10% each year for the last 5 years
  • First Script® has continuously reduced Morphine equivalent Dose (MED) over the last 9 years

Each part in the series is accompanied by an ongoing deeper dive into various related topics to address the specific trends highlighted in the infographics.

View the report: Coventry 2019 Workers’ Compensation Drug Trends Series Part 3

Source: Coventry

Disclosure:
Coventry is a WorkCompWire ad partner.
This is not a paid placement.

Filed Under: Association, Rating & Research News, Industry News, Top Stories, Workers' Compensation

Primary Sidebar

Get Our Free Newsletter:

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: WorkCompWire.com, PO Box 1114, Culver City, CA, 90232, http://www.workcompwire.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

myMatrixx

Paradigm

MSQ

Follow Us on Twitter

Tweets by WorkCompWire

Workers Compensation News Topics

  • Top Stories
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • The RxProfessor
  • Industry News
  • Association, Rating & Research News
  • People On The Move
  • Claims, Legal, & Compliance News
  • Legislative & Regulatory News
  • Risk Management News
  • Work Force & Human Resource News
  • Workers’ Compensation

Wire Archives

Copyright WorkCompWire © 2023